D-Day approaching for Cell Therapeutics' pixantrone

Submitted by Ross Bonander Thu 02/04/2010

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

On 10 February 2010, members of the FDA's Oncologic Drugs Advisory Committee will meet to hear testimony and debate whether or not to approve Cell Therapeutics' application to market pixantrone, the company's experimental drug to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

For Cell Therapeutics, it's fairly safe to say that the fate of the company relies on pixantrone's approval, which while not a sure thing, is nonetheless very likely. The drug has been proven to be fairly effective in tumor reduction and it seems to have a low cardiac toxicity profile. It has not been shown to extend patients' lives; fortunately for Cell Therapeutics, and perhaps not so fortunately for future patients, FDA approval doesn't hinge on this all-important factor.

By Ross Bonander

More on pixantrone from Cell Therapeutics.

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.